|
KIAA1549 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18419999999941E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.066400E-02 |
| Normal-vs-Stage2 |
8.16570000000683E-05 |
| Normal-vs-Stage3 |
1.46590000005276E-06 |
| Normal-vs-Stage4 |
3.45130000001248E-06 |
| Stage1-vs-Stage2 |
2.830000E-02 |
| Stage1-vs-Stage3 |
1.598000E-03 |
| Stage1-vs-Stage4 |
1.739550E-03 |
| Stage2-vs-Stage3 |
8.434000E-01 |
| Stage2-vs-Stage4 |
6.125400E-01 |
| Stage3-vs-Stage4 |
7.081200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.14570000000025E-05 |
| Normal-vs-AfricanAmerican |
4.181600E-03 |
| Normal-vs-Asian |
2.695600E-01 |
| Caucasian-vs-AfricanAmerican |
8.433400E-01 |
| Caucasian-vs-Asian |
7.341800E-01 |
| AfricanAmerican-vs-Asian |
6.918200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32699999999542E-06 |
| Normal-vs-Female |
9.584400E-03 |
| Male-vs-Female |
4.377700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.922000E-03 |
| Normal-vs-Age(41-60Yrs) |
8.006100E-04 |
| Normal-vs-Age(61-80Yrs) |
4.12349999999728E-05 |
| Normal-vs-Age(81-100Yrs) |
1.001980E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.239000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.497800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.722600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.989400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.807800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.431800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.943800E-01 |
| Normal-vs-Grade 2 |
2.411800E-02 |
| Normal-vs-Grade 3 |
9.66209999999634E-05 |
| Normal-vs-Grade 4 |
9.60331814070514E-12 |
| Grade 1-vs-Grade 2 |
2.597400E-01 |
| Grade 1-vs-Grade 3 |
6.518400E-02 |
| Grade 1-vs-Grade 4 |
6.33660000000091E-05 |
| Grade 2-vs-Grade 3 |
3.854100E-02 |
| Grade 2-vs-Grade 4 |
2.9460999972919E-08 |
| Grade 3-vs-Grade 4 |
1.000780E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.735400E-01 |
| Normal-vs-ccB subtype |
2.03737027248962E-12 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.21879999999786E-05 |
| Normal-vs-N1 |
2.192900E-04 |
| N0-vs-N1 |
2.090400E-01 |
|
|
